Next-generation nanomedicines and nanosimilars: EU regulators initiatives relating to the development and evaluation of nanomedicines
Ehmann, Falk, Sakai-Kato, Kumiko, Duncan, Ruth, Pérez de la Ossa, Dolores Hernán, Pita, Ruben, Vidal, Jean-Marc, Kohli, Ashish, Tothfalusi, Laszlo, Sanh, Alan, Tinton, Sandrine, Robert, Jean-Louis, Silva Lima, Beatriz, Amati, Marisa Papaluca
Published in Nanomedicine (London, England) (01.05.2013)
Published in Nanomedicine (London, England) (01.05.2013)
Get full text
Journal Article
Determining recommended acceptable intake limits for N-nitrosamine impurities in pharmaceuticals: Development and application of the Carcinogenic Potency Categorization Approach (CPCA)
Kruhlak, Naomi L., Schmidt, Marianne, Froetschl, Roland, Graber, Stefan, Haas, Bodo, Horne, Irene, Horne, Stephen, King, Sruthi T., Koval, Iryna A., Kumaran, Govindaraj, Langenkamp, Anja, McGovern, Timothy J., Peryea, Tyler, Sanh, Alan, Siqueira Ferreira, Aline, van Aerts, Leon, Vespa, Alisa, Whomsley, Rhys
Published in Regulatory toxicology and pharmacology (01.06.2024)
Published in Regulatory toxicology and pharmacology (01.06.2024)
Get full text
Journal Article
Next-generation nanomedicines and nanosimilars: EU regulators'initiatives relating to the development and evaluation of nanomedicines
Ehmann, Falk, Sakai-Kato, Kumiko, Duncan, Ruth, Pérez De La Ossa, Dolores Hernán, Pita, Ruben, Vidal, Jean-Marc, Kohli, Ashish, Tothfalusi, Laszlo, Sanh, Alan, Tinton, Sandrine, Robert, Jean-Louis, Silva Lima, Beatriz, Amati, Marisa Papaluca
Published in Nanomedicine (London, England) (01.05.2013)
Published in Nanomedicine (London, England) (01.05.2013)
Get full text
Journal Article